We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized, Double-Blind Active Comparator-Controlled Study of Rivoglitazone in Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00484198
Recruitment Status : Completed
First Posted : June 8, 2007
Last Update Posted : February 3, 2010
Sponsor:
Information provided by:
Daiichi Sankyo, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2009
  Study Completion Date : February 2009
  Certification or Request for Extension to Delay Results Submission: February 1, 2010